Composition and method for treating iron deficiency anemia

Details Composition and method for treating iron deficiency anemia Composition and method for treating iron deficiency anemia

2009-07-20

2011-12-20

Tsay, Marsha (Department: 1656)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

C514S005500, C514S502000, C530S385000

Reexamination Certificate

active

08080520

ABSTRACT:
A composition comprising heme iron and/or heme iron polypeptide in combination with ionic iron(s) and/or chelated iron(s). Administration of effective dosages of the present composition provides a method for treating and/or preventing iron deficiency anemia, and the physiological, biochemical, morphological, and behavioral manifestations symptomatic of same.

REFERENCES:
patent: 3821192 (1974-06-01), Montgomery et al.
patent: 4411915 (1983-10-01), Eriksson
patent: 5217998 (1993-06-01), Hedlund et al.
patent: 5631219 (1997-05-01), Rosenthal et al.
patent: 5919755 (1999-07-01), Kangassaho et al.
patent: 6197329 (2001-03-01), Hermelin et al.
patent: 6258846 (2001-07-01), Hermelin et al.
patent: 6569857 (2003-05-01), Hermelin et al.
patent: 6576666 (2003-06-01), Hermelin et al.
patent: 7112609 (2006-09-01), Hermelin et al.
patent: 7585527 (2009-09-01), Venkataraman et al.
patent: 2003/0170344 (2003-09-01), Russell et al.
patent: 2003/0190355 (2003-10-01), Hermelin et al.
patent: 2004/0176344 (2004-09-01), Rooney
patent: 2004/0254155 (2004-12-01), Bommer
patent: 2005/0020487 (2005-01-01), Klaus et al.
patent: 2005/0037065 (2005-02-01), Kirschner et al.
patent: 2663584 (2007-03-01), None
patent: 9313783 (1993-07-01), None
patent: 2007/003575 (2007-03-01), None
patent: 2007/035757 (2007-03-01), None
Order of Dismissal Pursuant to Fed. R. Civ. P. 4(m), issued inSeton Pharmaceuticals, LLCv.Alaven Pharmaceutical LLC, U.S.D.C. NJ, Civil Action No. 3:10-cv-02518-JAP, dated Nov. 29, 2010.
Nissenson et al. “Clinical Evaluation of Heme Iron Polypeptide: Sustaining a Response to rHuEPO in Hemodialysis Patients” American Journal of Kidney Diseases, vol. 42, No. 2 (Aug.), 2003: pp. 325-330.
Beard, John L. “Effectiveness and Strategies of Iron Supplementation During Pregnancy” American Journal for Clinical Nutrition; 71 (suppl): (2000), pp. 1288S-1294S.
Seligman et al. “Clinical Studies of Hip: An Oral Heme-Iron Product” Elsevier Science, Inc.—Nutrition Research, vol. 20, No. 9 (2000), pp. 1279-1285.
Roughead et al. “Initial Uptake and Absorption of Nonheme Iron and Absorption of Heme Iron In Humans are Unaffected by the Addition of Calcium as Cheese to a Meal With High Iron Bioavailability” American Journal for Clinical Nutrition, (2002) 76: pp. 419-425.
Roughead et al. “Adaptation in Iron Absorption: Iron Supplementation Reduces Nonheme-Iron but not Heme-Iron Absorption from Food” American Journal for Clinical Nutrition, (2000) 72: pp. 982-989.
Bereman et al. “The Structure, Size and Solution Chemistry of a Polysaccharide Iron Complex” Inorganica Chimica Acta, 155 (1989) pp. 183-189.
Beard, et al. “Iron Status and Exercise” American Journal for Clinical Nutrition, (2000) 72 (suppl): 594S-597S.
Gräsbeck et al. “An Intestinal Receptor for Heme” Scandinavian Journal of Hemotology (1979) vol. 23, pp. 5-9.
Uzel et al. “Absorption of Heme Iron” Seminars in Hematology, (Jan. 1998) vol. 35, No. 1, pp. 27-34.
Pizarro et al. “Heme-Iron Absorption is Saturable by Heme-Iron Dose in Women” Human Nutrition and Metabolism Research Communication, American Society for Nutritional Sciences (2003), pp. 2214-2217, vol. 133.
Ito et al., “Effect of Heme-Iron Food (BIOION 150) On Iron Deficiency and Iron Deficiency Anemia”, Japanese Journal of Clinical Nutrition, vol. 78, No. 7, (1991), pp. 841-846.
Hallberg et al., “Iron Absorption from the Whole Diet in Men: How Effective is the Regulation of Iron Absorption?”, The American Journal of Clinical Nutrition, (1997), pp. 347-356.
Hallberg et al., “Effect of Ascorbic Acid on Iron Absorption From Different Types of Meals. Studies with Ascorbic-Acid-Rich Foods and Synthetic Ascorbic Acid Given in Different Amounts with Different Meals”, Human Nutrition-Applied Nutrition, (Apr. 1986), pp. 97-113, (Pubmed abstract).
Sharma et al., “Effect of Omeprazole on Oral Iron Replacement in Patients with Iron Deficiency Anemia”, Southern Medical Journal, vol. 97, No. 9, (Sep. 2004), pp. 887-889.
Ekman et al., “Comparative Absorption of Ferrous and Heme-Iron with Meals in Normal and Iron Deficient Subjects”, Z Ernährungswissenschaft, vol. 32, (1993), pp. 67-70.
Sandstad et al.,“Selective Iron Supplementation Based on Serum Ferritin Values Early in Pregnancy: Are the Norwegian Recommendations Satisfactory?”, Acta Obstetricia et Gynecoligica Scandinavica, vol. 82, (2003), pp. 537-542.
Eskeland et al., “Iron Supplementation in Pregnancy: Is Less Enough?”, Acta Obstetricia et Gynecoligica Scandinavica, vol. 76, (1997), pp. 822-828.
Koren et al., “Compliance with Prenatal Vitamins”, Canadian Family Physician, vol. 52, (Nov. 2006), pp. 1392-1393.
Shayeghi et al., “Identificaiton of an Intestinal Heme Transporter” Cell, vol. 122, (Sep. 9, 2005), pp. 789-801.
Nancy C. Andrews, M.D., Ph.D., “Understanding Heme Transport”, The New England Journal of Medicine, 353:23, (Dec. 8, 2005), pp. 2508-2509.
Nancy C. Andrews, M.D., Ph.D., “Disorders of Iron Metabolism”, The New England Journal of Medicine, vol. 341, No. 26, (Dec. 23, 1999), pp. 1986-1996.
Piccinni et al., “Therapeutic Effectiveness of an Iron-Polysaccharide Complex in Comparison with Iron Fumarate in the Treatment of Iron Deficiency Anaemias”, Pan Medical, vol. 24, (1982), pp. 213-220.
Heffernan, et al., “Polysaccharide-Iron Complex Use in Chronic Dialysis Patients Receiving Erythropoietin”, (1991), pp. 1-22.
Newton et al., Prohylaxis of Iron Deficiency Anaemia of Prematurity, Clinical Trials Journal, vol. 17, No. 3, (1980), pp. 106-111.
Ghaddar et al., “Evaluation of the Ability of Heme Iron Polypeptide to Sustain Response to rHuEPO in Peritoneal Dialysis Patients: A Prospective Clinical Evaluation”, abstract presented at NFK, Apr. 7, 2003, Dallas, TX.
Casiday, R., et al., “Hemoglobin and the Heme Group: Metal Complexes in the Blood for Oxygen Transport” Washington University, Department of Chemistry, Jun. 21, 2007 (tutorial) 15 pages.
Colorado Biolabs, Inc.,“Proferrin® ES (heme iron polypeptide)—Product Ordering Information” pamphlet, Colorado Biolabs, Inc., Cozad, Nebraska, Mar. 2005.
Colorado Biolabs, Inc., “Proferrin® Forte (heme iron polypeptide with folic acid)” Product Literature; Colorado Biolabs, Inc., Cozad, Nebraska, Mar. 2005.
Colorado Biolabs, Inc.,“Proferrin® Forte (heme iron polypeptide with folic acid-medical food)” www.coloradobiolabs.com/ProferrinForte/default.aspx, Dec. 31, 2005.
Colorado Biolabs, Inc., Proferrin® (heme iron polypeptide), www.coloradobiolabs.com/default.aspx, Dec. 31, 2005.
Frykman, E. et al., “Side Effects of Iron Supplements In Blood Donors: Superior Tolerance of Heme Iron”, [Pub Med] Journal of Laboratory and Clinical Medicine, Apr. 1994, 561-4, (abstract).
[No author named] Research Database—International Updates Pregnancy / Menstruation Issue 30, www.positivehealth.com/permit/updates/redpreg.htm [date unknown] web accessed date Apr. 25, 2006.
[No author named] Hemofer, US Patent and Trademark Office Trademark Electronic Search System (TESS) www.uspto.gov [date unknown] web accessed date Apr. 25, 2006.
[No author named] Hemofer-B-Complex, www.comed.be/paarden/hemofere.htm [Date unknown] web accessed date Apr. 25, 2006.
[No author ] “Hemoglobin” Wikipedia, http://en.wikipedia.org/wiki/Hemoglobin web accessed date Oct. 17, 2007.
Britannica Online Encyclopedia—definition of partial acid hydrolysis (2009): 1 page.
MacDougal et al., “A randomized controlled study of iron supplementation in patients treated with erythropoietin” Kid Internat 1996; 50(5): 1694-1699.
Auerback et al., “A randomized trial of three iron dextan infusion methods for anemia in EPO-treated dialysis patients” Am J Kid Dis 1998; 31(1):

Affiliated with

Also associated with

Rating

Composition and method for treating iron deficiency anemia does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Composition and method for treating iron deficiency anemia, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Composition and method for treating iron deficiency anemia will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4271866